RxDoctor Payments Data

Emma Demorier, PA

Physician Assistant · Raleigh, NCNPI 1083151559

Payments from drug & device makers

$3,156in general payments, 2019–2025

Across 167 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$474
  • Otsuka America Pharmaceutical, Inc.$395
  • Vanda Pharmaceuticals Inc.$380
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$290
  • Alkermes, Inc.$250
  • Johnson & Johnson$197
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,144100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,156 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$4,226
Medicare patients
21
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl20$27,905
CaplytaLumateperone Tosylate12$20,295
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl87$9,035
Lurasidone Hcl29$3,135
SuboxoneBuprenorphine Hcl/Naloxone Hcl11$3,119
Clozapine22$1,949
Haloperidol Decanoate21$1,735
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$1,312
Quetiapine Fumarate70$1,072
Aripiprazole39$1,040
Gabapentin66$901
Mirtazapine24$508
Fluoxetine Hcl53$501
Duloxetine Hcl31$500
Olanzapine38$490

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$474$27,90520 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$290$20,29512 claims
Indivior Inc.Suboxone$80$3,11911 claims
Almatica Pharma LLCSertraline Hcl$53$21128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →